BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17900622)

  • 1. Interaction between CD14 and LXRbeta genes modulates Alzheimer's disease risk.
    Rodríguez-Rodríguez E; Sánchez-Juan P; Mateo I; Infante J; Sánchez-Quintana C; García-Gorostiaga I; Berciano J; Combarros O
    J Neurol Sci; 2008 Jan; 264(1-2):97-9. PubMed ID: 17900622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-gene interaction between heme oxygenase-1 and liver X receptor-beta and Alzheimer's disease risk.
    Infante J; Rodríguez-Rodríguez E; Mateo I; Llorca J; Vázquez-Higuera JL; Berciano J; Combarros O
    Neurobiol Aging; 2010 Apr; 31(4):710-4. PubMed ID: 18597895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD14 receptor polymorphism and Alzheimer's disease risk.
    Combarros O; Infante J; Rodríguez E; Llorca J; Peña N; Fernández-Viadero C; Berciano J
    Neurosci Lett; 2005 May 20-27; 380(1-2):193-6. PubMed ID: 15854776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.
    Arosio B; Trabattoni D; Galimberti L; Bucciarelli P; Fasano F; Calabresi C; Cazzullo CL; Vergani C; Annoni G; Clerici M
    Neurobiol Aging; 2004 Sep; 25(8):1009-15. PubMed ID: 15212825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association of genetic variants of liver X receptor-beta with Alzheimer's disease risk.
    Rodríguez-Rodríguez E; Llorca J; Mateo I; Infante J; Sánchez-Quintana C; García-Gorostiaga I; Fernández-Viadero C; Peña N; Berciano J; Combarros O
    Am J Med Genet B Neuropsychiatr Genet; 2008 Jul; 147B(5):650-3. PubMed ID: 18081155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease.
    Combarros O; van Duijn CM; Hammond N; Belbin O; Arias-Vásquez A; Cortina-Borja M; Lehmann MG; Aulchenko YS; Schuur M; Kölsch H; Heun R; Wilcock GK; Brown K; Kehoe PG; Harrison R; Coto E; Alvarez V; Deloukas P; Mateo I; Gwilliam R; Morgan K; Warden DR; Smith AD; Lehmann DJ
    J Neuroinflammation; 2009 Aug; 6():22. PubMed ID: 19698145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide.
    Liu Y; Walter S; Stagi M; Cherny D; Letiembre M; Schulz-Schaeffer W; Heine H; Penke B; Neumann H; Fassbender K
    Brain; 2005 Aug; 128(Pt 8):1778-89. PubMed ID: 15857927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
    Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
    Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels.
    Fenoglio C; Galimberti D; Lovati C; Guidi I; Gatti A; Fogliarino S; Tiriticco M; Mariani C; Forloni G; Pettenati C; Baron P; Conti G; Bresolin N; Scarpini E
    Neurobiol Aging; 2004 Oct; 25(9):1169-73. PubMed ID: 15312962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between Interleukin-18 gene promoter polymorphisms and onset of Alzheimer's disease.
    Segat L; Milanese M; Arosio B; Vergani C; Crovella S
    Neurobiol Aging; 2010 Jan; 31(1):162-4. PubMed ID: 18433937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-gene interaction between CARD8 and interleukin-6 reduces Alzheimer's disease risk.
    Fontalba A; Gutiérrez O; Llorca J; Mateo I; Vázquez-Higuera JL; Berciano J; Fernández-Luna JL; Combarros O
    J Neurol; 2009 Jul; 256(7):1184-6. PubMed ID: 19252766
    [No Abstract]   [Full Text] [Related]  

  • 12. Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer's disease risk.
    Combarros O; Sánchez-Juan P; Riancho JA; Mateo I; Rodríguez-Rodríguez E; Infante J; García-Gorostiaga I; Vázquez-Higuera JL; Berciano J
    J Neural Transm (Vienna); 2008 Jun; 115(6):863-7. PubMed ID: 18299793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Ser326Cys polymorphism in the DNA repair gene hOGG1 is not associated with sporadic Alzheimer's disease.
    Coppedè F; Mancuso M; Lo Gerfo A; Manca ML; Petrozzi L; Migliore L; Siciliano G; Murri L
    Neurosci Lett; 2007 Mar; 414(3):282-5. PubMed ID: 17240059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
    Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
    Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variability at the LXR gene (NR1H2) may contribute to the risk of Alzheimer's disease.
    Adighibe O; Arepalli S; Duckworth J; Hardy J; Wavrant-De Vrièze F
    Neurobiol Aging; 2006 Oct; 27(10):1431-4. PubMed ID: 16207502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism in the peroxisome proliferator-activated receptor alpha gene influences the risk for Alzheimer's disease.
    Brune S; Kölsch H; Ptok U; Majores M; Schulz A; Schlosser R; Rao ML; Maier W; Heun R
    J Neural Transm (Vienna); 2003 Sep; 110(9):1041-50. PubMed ID: 12938026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern.
    Letiembre M; Liu Y; Walter S; Hao W; Pfander T; Wrede A; Schulz-Schaeffer W; Fassbender K
    Neurobiol Aging; 2009 May; 30(5):759-68. PubMed ID: 17905482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association of interleukin-1beta polymorphism with Alzheimer's disease in the Jewish population.
    Rosenmann H; Meiner Z; Dresner-Pollak R; Kahana E; Aladjem Z; Grenader T; Wertman E; Abramsky O
    Neurosci Lett; 2004 Jun; 363(2):131-3. PubMed ID: 15172100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population [corrected].
    Pola R; Flex A; Gaetani E; Lago AD; Gerardino L; Pola P; Bernabei R
    Neuroreport; 2002 Sep; 13(13):1645-7. PubMed ID: 12352619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The LPS receptor (CD14) links innate immunity with Alzheimer's disease.
    Fassbender K; Walter S; Kühl S; Landmann R; Ishii K; Bertsch T; Stalder AK; Muehlhauser F; Liu Y; Ulmer AJ; Rivest S; Lentschat A; Gulbins E; Jucker M; Staufenbiel M; Brechtel K; Walter J; Multhaup G; Penke B; Adachi Y; Hartmann T; Beyreuther K
    FASEB J; 2004 Jan; 18(1):203-5. PubMed ID: 14597556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.